Timothy Alexander

Operation Warm Targets Clothing Insecurity With National PSA GLEN MILLS, PA — Operation Warm recently launched a national public service campaign from Glen Mills aimed at drawing attention to childhood clothing i […]

U.S. Sales Tax Rate Hits 10-Year High as Local Changes Accelerate KING OF PRUSSIA, PA — Vertex, Inc. (NASDAQ: VERX) reported that the average combined U.S. sales tax rate rose to 10.1881% in the first half of 2026, i […]

Hammer & Nails Expands to King of Prussia Town Center KING OF PRUSSIA, PA — Hammer & Nails Grooming for Guys will open a King of Prussia Town Center location Sept. 12, expanding the men’s grooming cha […]

McNees Adds Education Litigator as Plymouth Meeting Office Grows PLYMOUTH MEETING, PA — McNees Wallace & Nurick has added education litigator Macy Laster to its Plymouth Meeting office, expanding a suburban P […]

Made in Philadelphia Summer Market Debuts at Dilworth Park for Labor Day Weekend PHILADELPHIA, PA — More than 60 makers, artists, food vendors and small businesses will fill Dilworth Park over Labor Day weekend as a new open-air m […]

Chester Lacrosse Discovery Day Opens the Game to Local Youth CHESTER, PA — Children across Chester will get a chance to pick up a lacrosse stick, learn the game and play alongside new friends when the Chester L […]

Immaculata University Enrollment Rises for Second Straight Year IMMACULATA, PA — Immaculata University expects to welcome 495 new students this fall, extending enrollment growth for a second consecutive year as f […]

Cabaletta Targets 2027 BLA as Cell Therapy Trials Advance PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) is targeting a second-half 2027 Biologics License Application for rese-cel in myositis while p […]

Vishay Sets 10-Cent Quarterly Dividend, Payable in September MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) declared a quarterly dividend of 10 cents per share on its common and Class B common stock, c […]

Carpenter Technology Adds $1 Billion Buyback After Exhausting Plan PHILADELPHIA, PA — Carpenter Technology Corporation (NYSE: CRS) authorized an additional $1 billion share repurchase program after exhausting its p […]

Omega Flex Profit Falls 39% as Housing Weakness Hits Sales EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) reported a 38.5% drop in first-half net income as weaker housing activity reduced sales volumes and h […]

Toppoint Narrows Loss as Import, Metal Mix Lifts Margins NORTH WALES, PA — Toppoint Holdings Inc. (NYSE American: TOPP) narrowed its second-quarter net loss by 80% as revenue rose 17% and a shift toward h […]

ArriVent Nears Pivotal Lung Cancer Data With $373 Million Cash NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (NASDAQ: AVBP) is approaching a pivotal Phase 3 readout for its lead lung cancer drug while advancing t […]

NBME Doubles Medical School Scholarships Amid Physician Shortage PHILADELPHIA, PA — NBME doubled the number of awards in its medical school scholarship program for the 2026-2027 cycle, granting 20 students $10,000 e […]

Exyn Builds Defense Advisory Board to Scale Military Autonomy PHILADELPHIA, PA — Exyn Technologies (NASDAQ: EXYN, EXYNW) formed a Defense Advisory Board and named former Pentagon official and Green Beret Andrew K […]

Aprea Expands Cancer Trial as APR-1051 Shows Early Activity DOYLESTOWN, PA — Aprea Therapeutics, Inc. (NASDAQ: APRE) is expanding its Phase 1 trial of experimental cancer drug APR-1051 after reporting early s […]

Madrigal Adds J&J R&D Chief to Board as MASH Push Expands CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) appointed Johnson & Johnson research executive John C. Reed, M.D., Ph.D., to its b […]

Arbutus Plans $230 Million Share Buyback After Moderna Deal WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) plans to return up to approximately $230 million to shareholders after receiving $178.4 m […]

Mineralys Builds $661 Million War Chest Ahead of FDA Decision RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) ended the second quarter with $661.4 million in cash, cash equivalents and investments after r […]

Inhibikase Loss Widens as Phase 3 PAH Trial Expands WILMINGTON, DE— Inhibikase Therapeutics, Inc. (Nasdaq: IKT) nearly doubled its second-quarter net loss as spending increased on its Phase 3 pulmonary a […]